- Merck & Co. (Rahway, NJ)
- Job DescriptionThe Executive Director, Value & Implementation (V&I) Outcomes Research , position resides in the V&I organization, which includes Global Medical and ... Scientific Affairs as well as Outcomes Research .Under the guidance of a senior leader, this position...participate in and lead cross-functional teams is a critical part of this role. The Executive Director has scientific… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...time deliverables. Serve as the Operations Lead for clinical assets and associated studies. Step in as the… more
- Merck & Co. (Rahway, NJ)
- …be responsible for supporting the formulation development of new chemical entities as part of a matrix team from initial first in human formulations (suspensions, ... laboratory/pilot plant skills and fundamental scientific principles to utilize as part of their daily responsibilities.-Can understand overall project timelines to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines… more
- Merck & Co. (Rahway, NJ)
- …colleagues in Translational Medicine, as well as Discovery Sciences and late-stage Clinical Research while developing and expanding your career.This role will ... Translational Medicine-EU, Drug Metabolism/Modeling & Simulation, Regulatory Affairs, and late-stage Clinical Research throughout sites in the USA, UK and… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Merck & Co. (Rahway, NJ)
- …analytical, and physical characterization groups.- Outsource/coordinate formulation development or clinical manufacturing at Clinical Research ... be responsible for supporting the formulation development of new chemical entities as part of a matrix team from initial first in human formulations (suspensions,… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- … Clinical Operations Intern from June 2026 - December 2026. This position will be full- time (37.5 hours) in the summer and part - time (20 hours) for the ... primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. We are currently… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Merck & Co. (Rahway, NJ)
- Job DescriptionThe Analytical Research & Development department of our Company Research Laboratories Division is seeking applicants for a Principal Scientist ... position available at its Rahway, New Jersey research facility. We are looking for a collaborative, self-motivated scientific leader with expertise in biological… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Merck & Co. (Rahway, NJ)
- …and execute design verification strategies that successfully supports the clinical instruction(s) and commercial market approval(s) of combination products.Principal ... strategies for assigned drug-device combination product program(s) for successful clinical introduction(s) and commercial market(s) approval(s).Define design input(s)/ output(s)… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Daiichi Sankyo, Inc. (New York, NY)
- …primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. Summary: The Oncology ... hospitals, and community practices).Demonstrate understanding of current or pending clinical pathways in assigned accounts, and how they influence patient… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. SummaryUS Medical Affairs ... supervision and leadership of the Executive Director of Medical Research and Strategy, US Oncology Medical Affairs (USOMA). Develops...(USOMA). Develops the USOMA strategy and tactical plan as part of the US Brand Strategic Plan and leads… more
